What type of study is this?

This is a Quasi-Experimental study.

Effect of letrozole on shrinking the size of uterine fibroids in symptomatic patients of the reproductive age group

View Full Paper

Ask AI

Bookmark

Authors

Quasi-experimental study shows reduced mean fibroid size and symptom improvement in symptomatic patients, suggesting letrozole's potential benefits.

Letrozole therapy significantly reduced uterine fibroid size by 0.73 cm, with positive effects observed in two-thirds of patients.
The average pre-treatment fibroid size of 5.37 cm decreased to 4.64 cm post-treatment, indicating the effectiveness of letrozole.
This quasi-experimental study involved 30 women with symptomatic uterine fibroids, focusing on treatment outcomes over three months.
Findings highlight that letrozole can effectively control uterine fibroids with fewer adverse effects for patients within the reproductive age group.

Malik et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Quasi-experimental study shows reduced mean fibroid size and symptom improvement in symptomatic patients, suggesting letrozole's potential benefits.